Novoprotein Scientific Inc. (SHA:688137)

Novoprotein Scientific Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	687.77	-	863.7	929.92	189.39	68.68
Trading Asset Securities	-	-	621.7	966.85	-	25.14
Cash & Short-Term Investments	687.77	668.95	1,485	1,897	189.39	93.83
Cash Growth	-50.64%	-54.96%	-21.69%	901.50%	101.86%	2063.73%
Accounts Receivable	68.91	-	79.97	134.66	96.58	23.03
Other Receivables	4.38	-	3.45	10.35	2.95	7.53
Receivables	73.28	-	83.42	145	99.53	30.56
Inventory	70.61	-	84.97	77.08	37.19	18.71
Other Current Assets	1,103	-	416.41	16.29	6.11	2.37
Total Current Assets	1,935	-	2,070	2,135	332.22	145.47
Property, Plant & Equipment	180.11	-	133.92	134.98	137.95	12.77
Other Intangible Assets	18.16	-	18.71	18.18	6.71	0.11
Long-Term Deferred Tax Assets	35.24	-	27.94	18.51	12.96	10.7
Long-Term Deferred Charges	10.15	-	9.69	5.6	4.93	2.62
Other Long-Term Assets	25.89	-	38.45	21.05	18.33	0.27
Total Assets	2,214	-	2,299	2,333	513.1	171.93
Accounts Payable	36.88	-	17.94	20.9	23.64	8.22
Accrued Expenses	10.48	-	11.82	18.03	21.21	18.92
Current Portion of Leases	-	-	13.87	13.95	8.69	-
Current Income Taxes Payable	3.44	-	1.34	5.01	4.52	15.55
Current Unearned Revenue	4.62	-	4.19	4.81	11.61	13.24
Other Current Liabilities	3.93	-	0.97	1.32	2.11	11.4
Total Current Liabilities	74.47	-	50.12	64.02	71.78	67.33
Long-Term Leases	46.95	-	59.44	69.2	78.34	-
Long-Term Unearned Revenue	0.24	-	0.87	-	-	-
Long-Term Deferred Tax Liabilities	-	-	-	-	3.21	1.51
Total Liabilities	121.65	-	110.43	133.22	153.33	68.83
Common Stock	70.18	-	70.18	70.18	52.63	15.88
Additional Paid-In Capital	1,966	-	1,950	1,940	208.13	31.51
Retained Earnings	66.55	-	167.86	190.1	98.82	55.51
Comprehensive Income & Other	0.18	-	0.18	0.18	0.19	0.2
Shareholders' Equity	2,093	2,135	2,188	2,200	359.77	103.1
Total Liabilities & Equity	2,214	-	2,299	2,333	513.1	171.93
Total Debt	62.06	74.01	73.31	83.15	87.04	-
Net Cash (Debt)	625.72	594.94	1,412	1,814	102.36	93.83
Net Cash Growth	-52.26%	-57.87%	-22.14%	1671.86%	9.09%	28293.51%
Net Cash Per Share	8.79	8.47	19.79	31.79	2.56	5.91
Filing Date Shares Outstanding	69.46	70.39	70.18	70.18	52.63	15.88
Total Common Shares Outstanding	69.46	69.83	70.18	70.18	52.63	15.88
Working Capital	1,860	-	2,020	2,071	260.44	78.14
Book Value Per Share	30.13	30.57	31.19	31.35	6.84	6.49
Tangible Book Value	2,074	2,116	2,170	2,182	353.06	102.99
Tangible Book Value Per Share	29.86	30.31	30.92	31.09	6.71	6.48
Machinery	-	-	64.44	59.66	42.2	21.33
Construction In Progress	-	-	31.26	17.73	21.16	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.